FDA OK’s Rare Metabolic Disorder Tx; Junk on the Big Screen
0 Comments

Lumasiran (Oxlumo), the first treatment ever for the rare metabolic disorder primary hyperoxaluria type 1, gained FDA approval this week.

In an analysis of 250 major U.S. movies released from 1994 and 2018, the vast majority depicted very unhealthy diets. “[D]epicting unhealthy foods and beverages in media is a sociocultural problem that extends beyond advertisements,” said the report in JAMA Internal Medicine.

Vegan dieters saw 43% higher risk for total bone fractures and site-specific fractures compared to carnivores over an average 17.6-year period. (BMC Medicine)

The Mediterranean diet goes green: a new study found the tried-and-true diet supplemented with walnuts, green tea, Mankai, and with less meat and poultry yielded even greater cardiometabolic effects. (Heart)

Female reproductive steroids, estrogen, and progesterone may all be protective against COVID-19 symptoms due to their anti-inflammatory properties. (Trends in Endocrinology & Metabolism)

Substantial weight loss through lifestyle intervention is possible at any age. (ScienceDaily)

Adolescents who undergo sleeve gastrectomy may see a stark decline in bone mineral density thus weakening bones, researchers said. (Radiological Society of North America)

About 55% and 65% of current 20-year old men and women in India, respectively, are expected to develop diabetes during their lifetimes, with type 2 accounting for 95% of such cases. (Diabetologia)

  • Kristen Monaco is a staff writer, focusing on endocrinology, psychiatry, and dermatology news. Based out of the New York City office, she’s worked at the company for nearly five years.

Leave a Reply

Your email address will not be published. Required fields are marked *